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OBJECTIVES The purpose of this study was to determine, by analyzing the pressure-volume relationship,
the prognostic value of parameters related to myocardial energetics for predicting mortality in
patients with dilated cardiomyopathy (DCM) in sinus rhythm.
BACKGROUND The relationship between the myocardial energetics and the prognosis of patients with DCM
in sinus rhythm remains unclear.
METHODS We followed 114 ambulatory patients with nonischemic DCM in sinus rhythm for a mean
period of 5.8  3.9 years. Over 70% of our patients were in New York Heart Association
functional class I and class II. Pressure-volume data were obtained by the conductance
method, and myocardial oxygen consumption per beat (VO2) measurements were obtained.
RESULTS The 3-, 5-, and 10-year cumulative survival rates were 88.6%, 80.0%, and 73.9%, respectively.
Of the 114 patients, 47 were selected randomly to assess their myocardial energetics. By
univariate analysis, the mechanical efficiency (ME, external work/VO2), left ventricular (LV)
ejection fraction and the LV end-diastolic pressure were statistically associated with cardiac
death. The ME was the strongest predictor of survival in a Cox proportional-hazards analysis
(p  0.011). The best cutoff point of ME identified by the receiver-operating curve was 11%.
This value had a sensitivity of 100%, a specificity of 87% and an overall predictive accuracy
of 88% to distinguish survivors from nonsurvivors.
CONCLUSIONS This study clearly demonstrates that ME is a powerful clinical predictor for cardiac death in
patients with mild to moderate heart failure and with sinus rhythm. Whether these
conclusions apply to patients with more severe heart failure requires further
investigations. (J Am Coll Cardiol 2002;39:1264–8) © 2002 by the American College of
Cardiology Foundation
Dilated cardiomyopathy (DCM) is characterized by pro-
gressive left ventricular (LV) dilation and severely depressed
LV systolic function. It eventually culminates in end-stage
congestive heart failure and cardiac death (1,2). Therefore,
it is essential to identify, as early as possible, patients who
are unlikely to improve or stabilize with standard medical
treatment. Several studies have attempted to find clinical
and laboratory abnormalities associated with poorer prog-
nosis. These have included indices related to LV systolic
and diastolic function such as LV ejection fraction (LVEF),
LV end-diastolic dimensions and pressures and transmitral
inflow characteristics (2–5). One of the limitations of these
markers, however, is their load-dependence (6), which may
confound accurate assessment of LV systolic or diastolic
function and limit their predictive value. Recent studies
have focused on myocardial energetics as well as myocardial
function to elucidate the pathophysiology of DCM (7–10).
Analysis of the pressure-volume relationship provides a
better understanding of the myocardial energetics and
enables a fuller appreciation of the impaired energy gener-
ation in the diseased heart, which may be associated with a
poor prognosis in patients with DCM. However, no previ-
ous studies have evaluated the relationship between myo-
cardial energetics and the prognosis of patients with DCM.
Atrial fibrillation (AF) is common in patients with DCM
and is associated with a variety of potentially deleterious
hemodynamic consequences that might exert a negative
influence on prognosis and accelerate the progression of LV
systolic dysfunction (11,12). The overall survival rate for
patients in sinus rhythm has been found to be higher than
the rate for patients with AF (13). However, the prognostic
indicators in patients with DCM in sinus rhythm remain
unclear.
Accordingly, the purpose of this study was to determine
the prognostic value of myocardial energetics for predicting
mortality in patients with DCM in sinus rhythm by directly
measuring myocardial oxygen consumption and analyzing
the pressure-volume relationship.
METHODS
Patient population. The study population consisted of 114
consecutive ambulatory patients with nonischemic DCM in
sinus rhythm who were referred to Nagoya University
Hospital between February 1983 and October 1999. Di-
lated cardiomyopathy was defined as a decreased LVEF
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(50% as determined by contrast ventriculography) and a
dilated LV cavity in the absence of significant coronary
artery stenosis (50% as determined by coronary angiogra-
phy) or valvular heart disease, arterial hypertension, or
cardiac muscle disease caused by any known systemic disease
(14). A right or left ventricular biopsy was obtained to
confirm the diagnosis of DCM. Patients with AF were
excluded. The drug regimen at baseline consisted of diuret-
ics in 51 patients (46%), digitalis in 52 (47%), angiotensin-
converting enzyme (ACE) inhibitors in 37 (34%) and
beta-blockers in four (4%). Medical therapy during
follow-up was determined by the referring physicians and
was based on the clinical symptoms and course of the
disease, but there was no difference in beta-blocker use or
ACE inhibitor use over the course of the study. The study
protocol was approved by the appropriate institutional
review committee. Each patient gave written informed
consent before entering the study.
Cardiac catheterization. All medications were withheld
for the three days before the study. Selective coronary
angiography, left ventriculography, and cardiac biopsy were
performed by the femoral approach to confirm the diagnosis
of DCM. Of the 114 patients, 47 were selected randomly to
assess myocardial energetics. Because accurate assessment of
LV energetics requires an invasive protocol with extensive
instrumentation, we aimed to prove a prognostic value of
myocardial energetics using the minimum number of pa-
tients. A double-thermister catheter (model CCS/GOK,
Hilton-Webster Laboratories, Baldwin Park, California)
was placed in the coronary sinus through the brachial or
subclavian vein to measure myocardial blood flow. After left
ventriculography, when LV end-diastolic pressure returned
to baseline values, an eight-electrode volume conductance
catheter with a micromanometer tip (Leycom, Zoetermeer,
The Netherlands) was advanced to the LV to measure the
LV volume and pressure. A Fogarty catheter was placed in
the inferior vena cava and inflated transiently to determine
the LV end-systolic pressure-volume relationship. Arterial
and coronary sinus blood samples were drawn simulta-
neously to measure the oxygen saturation.
The LV pressure-volume data analysis. A volume-
conductance catheter was connected to a volumetric system
(model Sigma 5, Leycom, Oestgeest, The Netherlands) to
measure the LV volume conductance and convert it to the
LV volume. The LV volume obtained by the conductance
method was calibrated by biplane ventriculography (area-
length method) as described previously (8,9). An end-
systolic pressure-volume line was drawn on the left upper
corner of the pressure-volume loops of the initial 5 to 14
contractions during the transient decrease in preload caused
by the inflation of a Fogarty catheter. The LV contractility
index (Ees) was defined as the slope of the end-systolic
pressure-volume line (15). The pressure-volume area (PVA)
was defined as the area under the end-systolic pressure-
volume line and the systolic pressure-volume trajectory and
the end-diastolic pressure-volume relation curve. External
work (EW) was defined as the area within the pressure-
volume diagrams. The PVA and EW were measured in
millimeters of mercury (mm Hg) times milliliters and
converted to the dimensions of energy using the following
formula:
1 mm Hg  ml 1.33  104J 16
Myocardial oxygen consumption. Myocardial blood flow
was measured using a double-thermister catheter. The
coronary sinus flow was calculated according to the method
of Ganz et al. (17) using a computer system as described in
previous studies (8,9). Myocardial oxygen consumption per
minute was calculated as the product of coronary sinus flow
and the arterial-coronary sinus oxygen content difference.
Myocardial oxygen consumption per beat (VO2) was calcu-
lated as follows:
VO2J/beat	  20myocardial oxygen consumption/heart rate)
where 1 ml O2  20 J (16). Mechanical efficiency (ME) was
defined as the dimensionless ratio of EW to VO2.
Clinical and follow-up data. Demographic data at study
entrance were assessed by review of the visit and hospital
records. Survival and symptomatic status at follow-up were
also determined from review of this visit and hospital
records, when available, or by telephone contact with
patients, relatives, or the referring physician. A standard
questionnaire was used for the follow-up interviews.
Statistical analysis. Data are expressed as the mean
value  SD. Differences between survivors and nonsurvivors
were assessed using the unpaired t test, or chi-square
analysis, as appropriate. Cumulative survival estimates were
calculated using the Kaplan-Meier method, with differences
between the survival curves assessed by the log-rank test. To
identify the independent predictors of survival, the Cox
proportional hazards survival model was performed at the
significant variables by stepwise multiregression analysis.
Receiver-operating characteristic curves were constructed,
and a jackknife procedure was used to assess how well the
cutoff worked. A p value  0.05 was considered statistically
significant.
RESULTS
Patient characteristics. Patients were followed for an av-
erage of 5.8 years (range 0.7 to 10.9 years) starting from the
Abbreviations and Acronyms
AF  atrial fibrillation
DCM  dilated cardiomyopathy
Ees  end-systolic elastance
EW  external work
LV  left ventricular/ventricle
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PVA  pressure-volume area
VO2  myocardial oxygen consumption per beat
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catheterization and ending with a cardiac event or the most
recent data on the survivors. During the follow-up period, a
total of 114 patients (range 23 to 65 years; mean age 50 
12 years) were followed. Of these patients, four were
excluded because they died of non-cardiac causes. Nineteen
died of cardiac causes (16 patients with progressive heart
failure and 3 with sudden death). The 3-, 5- and 10-year
cumulative survival rates were 88.6%, 80.0% and 73.9%,
respectively (Fig. 1). There were no differences in the
number of patients with a familial history of DCM or
sudden death, exercise duration during treadmill tests, or
the occurrence of ventricular tachycardia between the sur-
vivors and nonsurvivors.
Hemodynamics and myocardial energetics. We randomly
selected 47 of the 114 patients to assess the parameters of
myocardial energetics. None of the selected 47 patients died
of non-cardiac causes. The selected group of 47 patients had
a somewhat better prognosis than the entire group of 110
patients, although the difference was not significant (p 
0.24; Fig. 1). There was no difference in the clinical and
hemodynamic characteristics between the entire group of
110 patients and the selected group of 47 patients (Table 1).
In the selected group, the LVEF was 37.1  12.0%, the Ees
was 1.20  0.64 mm Hg/ml, and the ME (EW/VO2) was
20.8  14.2%. These values were lower than normal in our
laboratory (18–20). There were significant differences in the
LVEF, the maximum first derivative of LV pressure (LV
dP/dt max), effective arterial elastance, PVA, EW, VO2 and
myocardial energy conversion (PVA/VO2) between the sur-
vivors and nonsurvivors (Table 2). In addition, the ME in
the nonsurvivors was extremely depressed compared with
the survivors (8.5  2.2% vs. 22.7  15.1%, respectively).
Univariate analysis of nonsurvivors. The findings of the
stepwise linear regression analysis for predicting mortality
from the measured variables indicated that the best predic-
tors of mortality were the ME (chi-square to remove 5.53;
p  0.01), LVEF (chi-square to remove 7.06; p  0.01) and
LV end-diastolic pressure (chi-square to remove 4.75; p 
0.01). Cox proportional-hazard regression analysis was per-
formed on ME, LVEF and LV end-diastolic pressure.
Figure 1. Kaplan-Meier survival curves for cardiac mortality of a larger
cohort of 110 patients (A), those of 47 selected patients who underwent
myocardial energetics measurements (B) and those of patients grouped
according to mechanical efficacy (ME) (C: ME 11%, D: ME 11%).
Table 1. Comparison Between All Patients and Patients With
Myocardial Energetics Measurements
All DCM
(n  110)
Myocardial
Energetics
Measurements
(n  47) p Value
Gender (M:F) 90:24 38:9 NS
Age (yrs) 50.2  12.2 50.4  11.9 NS
Familial history (%) 14.0 10.6 NS
NYHA functional class 1.8  0.7 1.8  0.6 NS
LVDd (cm) 6.3  0.9 6.1  0.7 NS
LVDs (cm) 5.2  1.0 5.0  0.7 NS
IVS (cm) 0.9  0.2 0.9  0.2 NS
LVPW (cm) 1.0  0.2 1.0  0.2 NS
LVMI (g/m2) 187  69 179  85 NS
LVEDP (mm Hg) 14  8 13  7 NS
LVEF (%) 37.4  13.0 37.1  12.0 NS
Data are presented as the mean value  SD or percentage of patients.
DCM  dilated cardiomyopathy; IVS  intraventricular septal thickness;
LVDd  left ventricular end-diastolic diameter; LVDs  left ventricular end-systolic
diameter; LVEDP  left ventricular end-diastolic pressure; LVEF  left ventricular
ejection fraction; LVMI  left ventricular mass index; LVPW  left ventricular
posterior wall thickness; NYHA  New York Heart Association.
Table 2. Basic Hemodynamic and Mechanoenergetic
Characteristics in 47 Patients With DCM in Sinus Rhythm
Survivors
(n  42)
Nonsurvivors
(n  5)
p
Value
Gender (M:F) 33:9 5:0 NS
Age (yrs) 50.6  11.5 55.6  5.4 NS
Familial history (%) 19.0 0 NS
NYHA functional class 1.8  0.6 1.7  0.5 NS
LVDd (cm) 6.1  0.6 6.1  1.0 NS
LVDs (cm) 5.0  0.7 4.9  1.0 NS
IVS (cm) 0.9  0.2 1.0  0.2 NS
LVPW (cm) 0.9  0.2 1.0  0.2 NS
LVMI (g/m2) 178  74 240  92 NS
HR (beat/min) 75  11 70  14 NS
SBP (mm Hg) 143  25 129  17 NS
DBP (mm Hg) 77  14 68  15 NS
PAWP (mm Hg) 10  5 9  3 NS
CI (l/min/m2) 2.9  0.5 2.6  0.4 NS
LVEDP (mm Hg) 14  7 11  5 NS
LVEF (%) 38.0  13.0 28.0  9.2 0.030
LV dP/dt max (mm Hg/s) 1237  297 990  138 0.002
LV dP/dt min (mm Hg/s) 1078  100 943  136 NS
Ees (mm Hg/ml) 1.21  0.67 1.18  0.30 NS
Ea (mm Hg/ml) 2.24  0.86 3.04  0.56 0.008
Ea/Ees 2.37  1.34 2.67  0.58 NS
EW (J/beat) 0.64  0.23 0.37  0.13  0.001
PVA (J/beat) 1.83  1.07 0.99  0.45 0.002
VO2 (J/beat) 3.42  1.70 4.93  0.90 0.014
EW/PVA (%) 38.4  12.8 38.7  8.9 NS
PVA/VO2 (%) 67.8  46.6 22.8  9.2  0.001
EW/VO2 (%) 22.7  15.1 8.5  2.2  0.001
Data are presented as the mean value  SD or percentage of patients.
CI  cardiac index; DBP  diastolic blood pressure; Ea  effective arterial
elastance; Ees  end-systolic elastance; EW  external work; EW/PVA  work
efficiency; EW/VO2  mechanical efficiency; HR  heart rate; PAWP  pulmonary
artery wedge pressure; PVA  pressure-volume area; SBP  systolic blood pressure;
VO2  myocardial oxygen consumption. Other abbreviations as in Table 1.
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Mechanical efficiency was the most important and indepen-
dent variable for predicting survival (p  0.011). The LVEF
and LV end-diastolic pressure were the next best predictive
variables but were not significant (p  0.058, p  0.884,
respectively).
Prognostic significance of mechanical efficiency. To
evaluate the further prognostic significance of the ME, a
receiver operating characteristic curve was constructed, and
it indicated that the best cutoff value for the ME was 11%.
This value had a sensitivity of 100%, a specificity of 87% and
an overall predictive accuracy of 88% in distinguishing
survivors from nonsurvivors using the jackknife procedure.
The patients whose ME was 11% had a significantly
reduced five-year survival rate of 58.3% compared with
those whose ME was 11%, who had a five-year survival
rate of 100% (p  0.001; Fig. 1).
DISCUSSION
Despite recent improvements in the medical management
of patients with DCM, the overall prognosis is still poor,
and heart transplantation often represents the only lifesav-
ing therapeutic option for these patients (1,2,4). Several
investigators (2–5) have tried to identify prognostic factors
that might predict a poor outcome in these patients in an
attempt to select patients appropriately for heart transplan-
tation or for more aggressive forms of treatment. Unfortu-
nately, no factor has proven to predict unequivocally the risk
of cardiac death or the need for heart transplantation. This
study is the first to report that an ME 11% is an
independent clinical predictor for survival in patients with
mild to moderate DCM in sinus rhythm.
Mechanoenergetic uncoupling in DCM. The ME of the
LV is defined as the fraction of total expended metabolic
energy that is converted into external contractile work (21).
The concept of ME includes information not only about
cardiac output but also about the concomitant energy cost.
Mechanical efficiency has been used mainly to assess and
optimize the effects of medical therapy in patients with
heart failure, and it has been suggested that ME is a very
sensitive parameter for characterizing LV performance by
taking into account the energy cost for a given level of
cardiac output (8,9,22), which may support our current
findings. In heart failure, the oxygen cost of contraction
remains relatively unchanged, despite markedly impaired
LV work, resulting in a decrease in the ME of contraction.
In fact, in the present study, patients with mild to moderate
DCM in sinus rhythm showed a remarkable decrease in the
ME defined as the ratio of external work to myocardial
oxygen consumption. Therefore, patients with DCM are
characterized by mechanoenergetic uncoupling, which is an
imbalance between LV performance and myocardial energy
consumption.
Comparison with previous studies. In most studies of
survival in DCM, the LVEF is undoubtedly the factor that
has received the most attention (2–4). In previous studies,
the LVEF was the single independent prognostic factor,
although other studies either did not support this observa-
tion (23,24) or found that the LVEF was less predictive
than other parameters such as the Doppler-derived dP/dt
(25) or the transmitral inflow characteristics (5). In a
previous study (4), an LVEF 20% was associated with a
one-year mortality of 30% in patients with DCM. Actually,
both the LVEF and the directly measured peak-positive
dP/dt were significantly higher in survivors than in nonsur-
vivors in the present study. However, we could not confirm
these variables to be significant prognostic predictors. These
differences may be explained by differences in the patient
populations. It is noteworthy that our patients showed a
favorable prognosis; the 5-year mortality was 20%, and the
10-year mortality was 26%. Our study consisted of a less
severely afflicted, ambulatory population of patients whose
mean LVEF was about 40% and had sinus rhythm. Over
70% of our patients were in New York Heart Association
(NYHA) functional class I and II, but most previous studies
were based on an analysis of patients in NYHA functional
class III and IV. In addition, most previous studies included
patients with AF.
Recent data in humans (11) have demonstrated that the
persistent irregularity in ventricular cycle lengths resulting
from AF adversely affects ventricular function and the
hemodynamic status, independent of the effect of AF upon
the ventricular rate. More recently, the presence of AF with
heart failure has been demonstrated (12) to be indepen-
dently associated with an increased risk for mortality. Thus,
we believe that our study is the first to demonstrate clearly
that ME is an important and powerful prognostic predictor
in clinically stable and ambulatory patients with DCM in
sinus rhythm.
Study limitations. Several methodological problems must
be discussed. First, the number of patients enrolled in the
present study was relatively small. In addition, this study
was performed in clinically stable and ambulatory patients in
sinus rhythm. Therefore, the results cannot be widely
extrapolated to patients with more severe LV dysfunction.
Further studies of larger numbers of patients are needed
before these conclusions can be applied more generally to
patients with LV dysfunction. Second, we assumed that the
LV volume obtained by the conductance catheter could be
reliable. It has been reported that the conductance catheter
may underestimate real volume when calibrated by using
blood conductivity and measuring parallel conductance by
injection of hypertonic saline solution (26,27). However, in
our previous study (8), we demonstrated the reproducibility
of measurements obtained by the same method as in the
present study. Furthermore, other methods of measuring
LV volume, such as two-dimensional echocardiogram or
radioisotope angiography, also have some limitations.
Conclusions. The present study can provide valuable prog-
nostic information in DCM patients in sinus rhythm with
mild to moderate LV dysfunction. The principal new
finding of the present study is that the assessment of ME is
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a powerful independent prognostic index. An ME 11%
can therefore help identify patients who are at risk for death
and may serve to select the optimal time at which heart
transplantation should be recommended to patients with
DCM in sinus rhythm when there are limited numbers of
donor hearts available. However, further investigations of
larger numbers of patients are needed before these conclu-
sions can be applied to patients with more severe LV
dysfunction.
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